نتایج جستجو برای: portal vein thrombosis pvt

تعداد نتایج: 132697  

Journal: :Acta gastro-enterologica belgica 2021

Portal vein thrombosis (PVT) is a splanchnic vascular disorder characterised by recent or chronic thrombotic occlusion of the portal venous system. Its aetiology miscellaneous, and its management demanding since PVT can play critical role as far morbidity mortality are concerned. Indeed, develop complication hypertension (PH), in association not with advanced liver disease, aggravate clinical c...

2011
Brintha K. Enestvedt C. Kristian Enestvedt Brian Diggs Susan L. Orloff

Background: Cirrhotic patients have higher rates of hypercoagulable disorders. We hypothesized that orthotopic liver transplant (OLT) recipients with pre-operative portal vein thrombosis (PVT) have more postoperative thrombotic events than those without PVT. Aims: To compare rates of post-op thrombotic events and outcomes between those with and without pre-op PVT. Methods: All OLT recipients be...

2013
Sabrina Kermiche-Rahali Aude Di Fiore Fanny Drieux Frédéric Di Fiore Arnaud François Michel Scotté

Sorafenib is a molecular-targeted therapy used in palliative treatment of advanced hepatocellular carcinoma (HCC) in Child-Pugh A patients. We describe the case of a patient who presented with a large HCC in the left liver associated with portal vein thrombosis (PVT). After 9 months of sorafenib treatment, reassessment showed that the tumors had decreased in size with recanalization of the port...

2009
Lucio Amitrano Maria Anna Guardascione

Portal vein thrombosis (PVT) not associated with hepatocellular carcinoma is considered a frequent complication of liver cirrhosis but, unlike PVT occurring in non-cirrhotic patients, very few data are available on its natural history and management. The reduced portal blood flow velocity is the main determinant of PVT but, as in other venous thromboses, multiple factors local and systemic, inh...

2014
Martin Rössle Birke Bausch Christoph Klinger

BACKGROUND Treatment of non-malignant portal vein thrombosis (PVT) in patients with cirrhosis has been neglected in the past because of the fear of bleeding complications when using anticoagulation and due to the technical difficulties associated with the implantation of the transjugular intrahepatic portosystemic shunt (TIPS). However, PVT has a negative impact on outcome and compromises liver...

Journal: :Blood 2012
Jasper H Smalberg Lidia R Arends Dominique C Valla Jean-Jacques Kiladjian Harry L A Janssen Frank W G Leebeek

Myeloproliferative neoplasms (MPNs) are the most common cause of Budd-Chiari syndrome (BCS) and nonmalignant, noncirrhotic portal vein thrombosis (PVT). In this meta-analysis, we determined the prevalence of MPNs and their subtypes as well as JAK2V617F and its diagnostic role in these uncommon disorders. MEDLINE and EMBASE databases were searched. Prevalence of MPNs, JAK2V617F, and MPN subtypes...

Journal: :Transplantation proceedings 2011
K Steinbrück M Enne R Fernandes J M Martinho E Balbi L Agoglia J Roma L F Pacheco-Moreira

BACKGROUND In living donor liver transplantation (LDLT), vascular complications are more frequently seen than in deceased donor transplantation. Early arterial, portal vein, or hepatic vein thromboses are complications that can lead to graft loss and patient death. The aim of this study was to assess the incidence, treatment, and outcome of vascular complications after LDLT in a single Brazilia...

2017
Alexandria D. McDow Anju Gurung Rama Poola Carmel Fratianni Marc Garfinkel Michael G. Jakoby

The hallmark manifestations of Cushing's syndrome (CS) are well known, but hypercoagulability is perhaps least recognized. Patients with CS are at increased risk of both spontaneous and postoperative thromboembolism, with the significant majority of events occurring in the lower extremity and pulmonary venous circulations. We present a case of portal vein thrombosis (PVT) occurring in the setti...

2017
Ahmed Hosni Abdelmaksoud Safaa Mandooh Mohamed Mahmoud Nabeel Tamer Mahmoud Elbaz Hend Ibrahim Shousha Ashraf Monier Inas Anwar Elattar Ashraf Omar Abdelaziz

Objective: Hepatocellular carcinoma with portal vein thrombosis is considered a relative contraindication for transarterial chemoembolization (TACE). The aim of our study was to evaluate the prognostic factors and management in patients with hepatocellular carcinoma with portal vein thrombosis (PVT). Methods: Between February 2011 and February 2015, 140 patients presented to our specialized mul...

Journal: :Blood 2008
Jean-Jacques Kiladjian Francisco Cervantes Franck W G Leebeek Christophe Marzac Bruno Cassinat Sylvie Chevret Dominique Cazals-Hatem Aurélie Plessier Juan-Carlos Garcia-Pagan Sarwa Darwish Murad Sebastian Raffa Harry L A Janssen Claude Gardin Sophie Cereja Carole Tonetti Stéphane Giraudier Bertrand Condat Nicole Casadevall Pierre Fenaux Dominique C Valla

Myeloproliferative diseases (MPDs) represent the commonest cause of splanchnic vein thrombosis (SVT), including Budd-Chiari syndrome (BCS) and portal vein thrombosis (PVT), but their diagnosis is hampered by changes secondary to portal hypertension, while their influence in the outcome of SVT remains unclear. We assessed the diagnostic and prognostic value of JAK2 and MPL515 mutations in 241 SV...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید